126 related articles for article (PubMed ID: 7519003)
1. Development of a human immunodeficiency virus-1 in vitro DNA synthesis system to study reverse transcriptase inhibitors.
Borroto-Esoda K; Boone LR
Antiviral Res; 1994 Apr; 23(3-4):235-49. PubMed ID: 7519003
[TBL] [Abstract][Full Text] [Related]
2. Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays.
Gu Z; Quan Y; Li Z; Arts EJ; Wainberg MA
J Biol Chem; 1995 Dec; 270(52):31046-51. PubMed ID: 8537362
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.
Reardon JE; Miller WH
J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
5. Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases.
Amacker M; Hübscher U
J Mol Biol; 1998 May; 278(4):757-65. PubMed ID: 9614940
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
Jaju M; Beard WA; Wilson SH
J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
[TBL] [Abstract][Full Text] [Related]
7. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
Pokholok DK; Gudima SO; Yesipov DS; Dobrynin VN; Rechinsky VO; Kochetkov SN
FEBS Lett; 1993 Jul; 325(3):237-41. PubMed ID: 7686510
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of HIV-1 reverse transcriptase and fidelity of in vitro DNA replication.
Abbotts J; Wilson SH
J Enzyme Inhib; 1992; 6(1):35-46. PubMed ID: 1285301
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
[TBL] [Abstract][Full Text] [Related]
11. Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively.
Gu Z; Li X; Quan Y; Parniak MA; Wainberg MA
J Virol; 1996 Apr; 70(4):2620-6. PubMed ID: 8642696
[TBL] [Abstract][Full Text] [Related]
12. Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.
Vrang L; Oberg B; Löwer J; Kurth R
Antimicrob Agents Chemother; 1988 Nov; 32(11):1733-4. PubMed ID: 2472774
[TBL] [Abstract][Full Text] [Related]
13. 3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition.
Freeman GA; Rideout JL; Miller WH; Reardon JE
J Med Chem; 1992 Aug; 35(17):3192-6. PubMed ID: 1380561
[TBL] [Abstract][Full Text] [Related]
14. Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3'-azido-3'-deoxythymidine (AZT)-resistant polymerase to AZT-5'-triphosphate.
Odriozola L; Cruchaga C; Andréola M; Dollé V; Nguyen CH; Tarrago-Litvak L; Pérez-Mediavilla A; Martínez-Irujo JJ
J Biol Chem; 2003 Oct; 278(43):42710-6. PubMed ID: 12917424
[TBL] [Abstract][Full Text] [Related]
15. Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
Arts EJ; Marois JP; Gu Z; Le Grice SF; Wainberg MA
J Virol; 1996 Feb; 70(2):712-20. PubMed ID: 8551607
[TBL] [Abstract][Full Text] [Related]
16. Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance.
Vaccaro JA; Anderson KS
Biochemistry; 1998 Oct; 37(40):14189-94. PubMed ID: 9760256
[TBL] [Abstract][Full Text] [Related]
17. The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template.
Ma QF; Bathurst IC; Barr PJ; Kenyon GL
Biochemistry; 1992 Feb; 31(5):1375-9. PubMed ID: 1371070
[TBL] [Abstract][Full Text] [Related]
18. New thymidine triphosphate analogue inhibitors of human immunodeficiency virus-1 reverse transcriptase.
Ma QF; Bathurst IC; Barr PJ; Kenyon GL
J Med Chem; 1992 May; 35(11):1938-41. PubMed ID: 1375962
[TBL] [Abstract][Full Text] [Related]
19. Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformate. Implications for multiple drug resistance.
Im GJ; Tramontano E; Gonzalez CJ; Cheng YC
Biochem Pharmacol; 1993 Dec; 46(12):2307-13. PubMed ID: 7506027
[TBL] [Abstract][Full Text] [Related]
20. Effects of beta-L-3'-azido-3'-deoxythymidine 5'-triphosphate on host and viral DNA polymerases.
Faraj A; El Alaoui AM; Gosselin G; Imbach JL; Morrow C; Sommadossi JP
Antiviral Res; 2000 Aug; 47(2):97-102. PubMed ID: 10996397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
